(Sharecast News) - Celadon Pharmaceuticals announced a strategic collaboration with Danish pharmaceutical company Valeos Pharma on Wednesday, to accelerate the production and supply of high-THC medical cannabis across Europe.
The AIM-traded firm said that under the framework agreement, Celadon would licence its genetics to Valeos for cultivation, allowing the two companies...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE